File size: 472kb | Date: 1 December 2017 | Clinical Statements - PDF
FSRH's Clinical Effectiveness Unit (CEU) reviews an observational study published in the New England Journal of Medicine. The study reports that, in the Danish study population, women who were currently using any method of hormonal contraception* (HC) or had done so within the last 6 months were 20% more likely to be diagnosed with breast cancer than those who had never used HC.
File size: 268kb | Date: 1 October 2017 | Clinical Statements - PDF
The National Institute for Health and Care Excellence (NICE) has decided not to update their 2005 guidance on long-acting reversible contraception (LARC) at this time because changes to the current recommendations are not required.
File size: 258kb | Date: 1 October 2017 | Clinical Statements - PDF
This statement provides guidance on contraceptive choices for transgender and non-binary people and their partners, who are engaging in vaginal sex where there is a risk of pregnancy. The statement also offers general sexual health advice for these groups.
File size: 292kb | Date: 1 March 2017 | Clinical Statements - PDF
This statement aims to encourage the consistent and safe management of women requesting intrauterine contraception (IUC) and subdermal implants (SDI) who are taking anticoagulants or antiplatelet medications. It is primarily aimed at clinicians working in primary care and community sexual and reproductive health clinics.
File size: 110kb | Date: 4 December 2016 | Clinical Statements - PDF
A recently published multinational trial reports no pregnancies among 311 women who extended use of their existing Nexplanon® to four years and 204 women who continued to five years of use.[
File size: 164kb | Date: 1 October 2016 | Clinical Statements - PDF
This statement is a CEU response to a study published in JAMA Psychiatry titled Association of Hormonal Contraception with Depression.
File size: 167kb | Date: 1 August 2016 | Clinical Statements - PDF
Updated Document - Please note, this document was updated in September 2016.
File size: 167kb | Date: 28 July 2016 | Clinical Statements - PDF
After reviewing the available body of evidence, the Centers for Disease Control (CDC) in the USA have concluded that a causal relationship exists between prenatal Zika virus infection and microcephaly and other serious brain anomalies. Cases of locally-transmitted Zika virus are still being reported in Brazil and most of its neighbouring countries.
File size: 192kb | Date: 1 November 2015 | Clinical Statements - PDF
The FSRH welcomes the publication of the new NICE Menopause Guideline in November 2015 which includes 64 recommendations relevant to UK clinical practice.
File size: 44kb | Date: 1 October 2015 | Clinical Statements - PDF
A large observational study from the United States found that the risk of unintended pregnancy after Essure sterilisation was similar to that after surgical sterilisation. However just over 2% of women who had Essure sterilisation required a further operation related to the sterilisation procedure within a year.
Share on twitter
Share on LinkedIn
Share on Facebook
Email to a friend
Print page